Organogenesis Holdings (ORGO) Operating Expenses (2016 - 2026)

Organogenesis Holdings' Operating Expenses history runs 11 years deep, the most recent figure standing at $106.1 million for Q1 2026.

• On a quarterly basis, Operating Expenses fell 6.45% year-over-year to $106.1 million in Q1 2026; TTM through Mar 2026 was $781.7 million, a 289.91% increase from a year earlier, with the FY2025 full-year figure at $519.5 million, up 348.83% from the prior year.
• Operating Expenses slipped to $106.1 million in Q1 2026 per ORGO's latest filing, from $431.9 million in the prior quarter.
• Across five years, Operating Expenses topped out at $431.9 million in Q4 2025 and bottomed at $26.8 million in Q3 2024.
• The 5-year median for Operating Expenses is $85.0 million (2023), against an average of $106.6 million.
• Across the five-year window, Operating Expenses sank 82.71% in 2024 and surged 1290.84% in 2025, its largest moves.
• Year by year, Operating Expenses stood at $79.7 million in 2022, then surged by 125.42% to $179.6 million in 2023, then sank by 82.71% to $31.1 million in 2024, then jumped by 1290.84% to $431.9 million in 2025, then plunged by 75.43% to $106.1 million in 2026.
• Per Business Quant, the three latest ORGO Operating Expenses figures stand at $106.1 million (Q1 2026), $431.9 million (Q4 2025), and $130.1 million (Q3 2025).